结核病疫苗研发的关键进展 - - 成功与挑战
Rocky Lai1, Abiola F Ogunsola1, Tasfia Rakib1
1Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA, USA.
NPJ vaccines
|October 12, 2023
概括
新型结核病 (TB) 疫苗显得有前途,提供了超越现有细菌卡尔梅特-盖林 (BCG) 疫苗的保护的希望. 研究强调了推进疫苗候选人,免疫标记物和改善的动物模型,用于结核病疫苗开发.
科学领域:
- * 免疫学和疫苗学
- * 传染病研究研究
- *临床和临床前发展
背景情况:
- *最近结核病 (TB) 疫苗开发的突破表明了潜在的范式转变.
- *该领域对新型疫苗候选人持乐观态度,这是自细菌卡尔梅特-盖林 (BCG) 疫苗以来的首次.
研究的目的:
- * 审查目前正在开发中的结核病疫苗.
- *讨论结核病疫苗研究中乐观的基础.
- * 探索保护的免疫相关物 (CoP) 和新的动物模型.
主要方法:
- *对临床和临床前结核病疫苗开发数据的审查.
- * 分析免疫特征作为保护的潜在相关性.
- *评估用于结核病疫苗测试的新动物模型.
主要成果:
- * 几种新的结核病疫苗候选人正在临床和临床前开发中取得进展.
- *识别潜在的免疫保护相关物 (CoP) 正在推进疫苗比较.
- *正在开发新的动物模型,以更好地反映人类结核病理学和免疫反应.
结论:
- *开发一种新的,保护性结核病疫苗似乎是可行的.
- * 相关的保护和先进的动物模型对于未来的疫苗疗效评估至关重要.
- *这些领域的持续研究对于控制全球结核病流行至关重要.
相关概念视频
Pulmonary Tuberculosis IV
146
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
146
Pulmonary Tuberculosis V
184
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
184
Microorganisms in Medicine and Therapeutics
36
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
36
Pulmonary Tuberculosis I
247
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
247
Pulmonary Tuberculosis II
244
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
244
Vaccinations
44.6K
Overview
44.6K


